Skip to Main Content

Author Details

Brad H Rovin
the Ohio State University Wexner Medical Center
1980
349
68
PMIDPaper TitleJournal TitlePublished Year
37947366Kidney Outcomes and Preservation of Kidney Function With Obinutuzumab in Patients With Lupus Nephritis: A Post Hoc Analysis of the NOBILITY Trial.Arthritis Rheumatol2024
37947366Kidney Outcomes and Preservation of Kidney Function With Obinutuzumab in Patients With Lupus Nephritis: A Post Hoc Analysis of the NOBILITY Trial.Arthritis Rheumatol2024
37914086Results of a randomized double-blind placebo-controlled Phase 2 study propose iptacopan as an alternative complement pathway inhibitor for IgA nephropathy.Kidney Int2024
37914086Results of a randomized double-blind placebo-controlled Phase 2 study propose iptacopan as an alternative complement pathway inhibitor for IgA nephropathy.Kidney Int2024
36344211Characterization of Glomerular and Tubulointerstitial Proteomes in a Case of Nonsteroidal Anti-Inflammatory Drug-Attributed Acute Kidney Injury: A Clinical Pathologic Molecular Correlation.Clin J Am Soc Nephrol2023
36344211Characterization of Glomerular and Tubulointerstitial Proteomes in a Case of Nonsteroidal Anti-Inflammatory Drug-Attributed Acute Kidney Injury: A Clinical Pathologic Molecular Correlation.Clin J Am Soc Nephrol2023
36270561Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy.Kidney Int2023
37607780Anifrolumab in lupus nephritis: results from second-year extension of a randomised phase II trial.Lupus Sci Med2023
38025219Urine and Plasma Complement Ba Levels During Disease Flares in Patients With Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis.Kidney Int Rep2023
37591292Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial.Lancet2023
37802003Urine Proteomics Link Complement Activation with Interstitial Fibrosis/Tubular Atrophy in Lupus Nephritis Patients.Semin Arthritis Rheum2023
37705915Effect of Belimumab on Preventing <i>de novo</i> Renal Lupus Flares.Kidney Int Rep2023
37471101Anti-PLA2R Antibody Levels and Clinical Risk Factors for Treatment Nonresponse in Membranous Nephropathy.Clin J Am Soc Nephrol2023
37085265The authors reply.Kidney Int2023
37085263The authors reply.Kidney Int2023
37085260The authors reply.Kidney Int2023
37085253Resolving a paradox between mouse and man: a genetic link between TLR7 and the pathogenesis of human lupus nephritis.Kidney Int2023
37085251Update on scoring and providing evidence basis for assessing pathology in lupus nephritis.Kidney Int2023
37085250Series introduction: drug repurposing for kidney diseases.Kidney Int2023
37463054Effect of belimumab on kidney-related outcomes in patients with lupus nephritis: post hoc subgroup analyses of the phase 3 BLISS-LN trial.Nephrol Dial Transplant2023
37333123The chromatin landscape of healthy and injured cell types in the human kidney.bioRxiv2023
36948770IgA nephropathy and glucocorticoids-a limbo dance?Kidney Int2023
37263354IgA nephropathy: the lectin pathway and implications for targeted therapy.Kidney Int2023
36754010Exploring the Role of Antithrombin in Nephrotic Syndrome-Associated Hypercoagulopathy: A Multi-Cohort Study and Meta-Analysis.Clin J Am Soc Nephrol2023
37258036Remission of lupus nephritis: the trajectory of histological response in successfully treated patients.Lupus Sci Med2023
37441464Clinical Outcomes in Patients With Biopsy Proven Anticoagulant-Related Nephropathy.Kidney Int Rep2023
37180506IgA Nephropathy Patient Baseline Characteristics in the Sparsentan PROTECT Study.Kidney Int Rep2023
37180505Targeting the Alternative Complement Pathway With Iptacopan to Treat IgA Nephropathy: Design and Rationale of the APPLAUSE-IgAN Study.Kidney Int Rep2023
37165898Development of American College of Rheumatology Quality Measures for Systemic Lupus Erythematosus: A Modified Delphi Process With Rheumatology Informatics System for Effectiveness (RISE) Registry Data Review.Arthritis Care Res (Hoboken)2023
37103889Budesonide delayed-release capsules to reduce proteinuria in adults with primary immunoglobulin A nephropathy.Expert Rev Clin Immunol2023
37419616N-acetylcysteine ameliorates hematuria-associated tubulointerstitial injury in 5/6 nephrectomy mice.Physiol Rep2023
38025219Urine and Plasma Complement Ba Levels During Disease Flares in Patients With Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis.Kidney Int Rep2023
37802003Urine Proteomics Link Complement Activation with Interstitial Fibrosis/Tubular Atrophy in Lupus Nephritis Patients.Semin Arthritis Rheum2023
37591292Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial.Lancet2023
37705915Effect of Belimumab on Preventing <i>de novo</i> Renal Lupus Flares.Kidney Int Rep2023
37607780Anifrolumab in lupus nephritis: results from second-year extension of a randomised phase II trial.Lupus Sci Med2023
37258036Remission of lupus nephritis: the trajectory of histological response in successfully treated patients.Lupus Sci Med2023
37419616N-acetylcysteine ameliorates hematuria-associated tubulointerstitial injury in 5/6 nephrectomy mice.Physiol Rep2023
37085265The authors reply.Kidney Int2023
37085263The authors reply.Kidney Int2023
37085260The authors reply.Kidney Int2023
37085253Resolving a paradox between mouse and man: a genetic link between TLR7 and the pathogenesis of human lupus nephritis.Kidney Int2023
37085251Update on scoring and providing evidence basis for assessing pathology in lupus nephritis.Kidney Int2023
37085250Series introduction: drug repurposing for kidney diseases.Kidney Int2023
36948770IgA nephropathy and glucocorticoids-a limbo dance?Kidney Int2023
37180506IgA Nephropathy Patient Baseline Characteristics in the Sparsentan PROTECT Study.Kidney Int Rep2023
37180505Targeting the Alternative Complement Pathway With Iptacopan to Treat IgA Nephropathy: Design and Rationale of the APPLAUSE-IgAN Study.Kidney Int Rep2023
37441464Clinical Outcomes in Patients With Biopsy Proven Anticoagulant-Related Nephropathy.Kidney Int Rep2023
37103889Budesonide delayed-release capsules to reduce proteinuria in adults with primary immunoglobulin A nephropathy.Expert Rev Clin Immunol2023
37333123The chromatin landscape of healthy and injured cell types in the human kidney.bioRxiv2023
  • 1 - 50 of 698

Recommended Authors

Laura H Mariani
University of Michigan ann arbor
Career Start Year 2011
Number of shared co-authors 25
Luis M Ortega
Alegheny General Hospital, Temple University School of Medicine
Career Start Year 2009
Number of shared co-authors 1
Rajaie Namas
Medical Subspecialities Institute, Cleveland Clinic
Career Start Year 2008
Number of shared co-authors 1
Avi Z Rosenberg
Johns Hopkins University
Career Start Year 2006
Number of shared co-authors 21
Maddalena Marasa
Columbia University College of Physicians and Surgeons
Career Start Year 2004
Number of shared co-authors 8
Jakub Z??vada
Institute of Rheumatology, Charles University
Career Start Year 2003
Number of shared co-authors 1
Celine C Berthier
University of Michigan ann arbor
Career Start Year 2003
Number of shared co-authors 15
Mark S Segal
University of Florida
Career Start Year 2001
Number of shared co-authors 1
Vimal K Derebail
University of North Carolina at Chapel Hill
Career Start Year 2000
Number of shared co-authors 15
Serhan Tuglular
Marmara University
Career Start Year 1999
Number of shared co-authors 0
Shinsuke Yasuda
Tokyo Medical and Dental University
Career Start Year 1998
Number of shared co-authors 0
Maja T Lindenmeyer
University Medical Center Hamburg-Eppendorf
Career Start Year 1998
Number of shared co-authors 8
David B Thomas
Duke University
Career Start Year 1997
Number of shared co-authors 6
Robert MacGinley
Eastern Health Clinical School, Monash University
Career Start Year 1997
Number of shared co-authors 0
Michael Rudnicki
Medical University Innsbruck
Career Start Year 1997
Number of shared co-authors 3
Mukut Sharma
Midwest Veterans' Biomedical Research Foundation, KCVA Medical Center
Career Start Year 1996
Number of shared co-authors 1
Clemens D Cohen
Medical Clinic and Policlinic IV, University of Munich
Career Start Year 1996
Number of shared co-authors 13
Rohan John
University of Toronto
Career Start Year 1996
Number of shared co-authors 7
Bernd Schr??ppel
Ulm University
Career Start Year 1995
Number of shared co-authors 5
Markus Bitzer
University of Michigan ann arbor
Career Start Year 1994
Number of shared co-authors 14
Carolina Landolt-Marticorena
Krembil Research Institute, University Health Network
Career Start Year 1993
Number of shared co-authors 8
Jun Oh
Konyang University Hospital
Career Start Year 1993
Number of shared co-authors 3
Roslyn B Mannon
University of Nebraska Medical Center
Career Start Year 1992
Number of shared co-authors 1
Susan F Massengill
Levine Children's Hospital at Atrium Health
Career Start Year 1992
Number of shared co-authors 8
Paul R Fortin
Centre de recherche du Centre hospitalier universitaire de Quebec-Universite Laval
Career Start Year 1991
Number of shared co-authors 10
Maria Pia Rastaldi
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Career Start Year 1991
Number of shared co-authors 8
Minoru Satoh
University of Occupational and Environmental Health
Career Start Year 1986
Number of shared co-authors 1
Maura Rossetti
University of California Los Angeles
Career Start Year 1986
Number of shared co-authors 0
Jeffrey B Kopp
National Institutes of Health, National Institute of Diabetes
Career Start Year 1983
Number of shared co-authors 25
Detlef Schl??ndorff
Icahn School of Medicine at Mount Sinai
Career Start Year 1976
Number of shared co-authors 4

Collaborators

Samir M Parikh
The Ohio State University Wexner Medical Center
Co-authored papers 47
Isabelle Ayoub
Wexner Medical Center, The Ohio State University
Co-authored papers 23
Ana Malvar
Hospital Fernandez
Co-authored papers 23
Salem Almaani
The Ohio State University College of Medicine
Co-authored papers 16
Jon B Klein
Co-authored papers 13
Valeria Alberton
Hospital Fernandez
Co-authored papers 10
Heather N Reich
University Health Network and University of Toronto
Co-authored papers 9
James A Tumlin
Emory University
Co-authored papers 9
Lianbo Yu
The Ohio State University
Co-authored papers 8
Michelle Petri
Co-authored papers 8
Stacy P Ardoin
Co-authored papers 6
Nizar N Jarjour
Co-authored papers 6
Debbie S Gipson
University of Michigan ann arbor
Co-authored papers 6
Hans-Joachim Anders
University Hospital of the Ludwig Maximilians University Munich
Co-authored papers 6
Michael T Eadon
Co-authored papers 5
Matthias Kretzler
University of Michigan ann arbor
Co-authored papers 5
Jianying Zhang
City of Hope National Medical Center
Co-authored papers 5
Michael J Fine
University of Pittsburgh School of Medicine
Co-authored papers 5
Robert G Nelson
National Institute of Diabetes and Digestive and Kidney Diseases
Co-authored papers 5
Tarek M El-Achkar
Co-authored papers 4
Jonathan Himmelfarb
Kidney Research Institute and Division of Nephrology, University of Washington
Co-authored papers 4
Daria Barwinska
Co-authored papers 4
Ramachandran S Vasan
Co-authored papers 4
Pierre C Dagher
Co-authored papers 4
Karen H Costenbader
Co-authored papers 4
Krzysztof Kiryluk
Columbia University
Co-authored papers 4
Sushrut S Waikar
Boston University Chobanian & Avedisian School of Medicine, Boston Medical Center
Co-authored papers 4
Carmen Avila-Casado
University Health Network
Co-authored papers 4
Murray B Urowitz
Schroeder Arthritis Institute, Krembil Research Institute, University Health Network
Co-authored papers 3
Michael J Ferkowicz
Co-authored papers 3
Release 1.2